PRETOMANID: US FDA approves new drug for drug-resistant TB
United States (US) Food and Drug Administration (FDA) has approved new drug-Pretomanid for treating drug-resistant strain of Tuberculosis (TB). Pretomanid is novel compound developed by New York-based non-profit organisation TB Alliance. It is used alongside two other antibiotics (bedaquiline and ..
Tags: Bedaquiline • BPaL regimen • Diseases • Drug resistant TB • Linezolid
Month: Current Affairs - August, 2019
India makes alliance with US to eliminate TB
India has made alliance with United States in public and private sectors to combat the menace of Tuberculosis (TB). The formation of ‘USAID-India End TB Alliance’ was formally announced by the US Agency for International Development (USAID) administrator Mark Green ..
Tags: Health • TB Alliance • Tuberculosis • Tuberculosis in India